Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

Q2 2025 Management View John G. Houston, Chairperson, CEO & President, stated the quarter was eventful with "significant clinical and regulatory programs across our pipeline of PROTAC degraders." He ...

While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in ...

Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value. The ex-Pfizer executives, Ian Read and ...

The issuer is solely responsible for the content of this announcement.

Pfizer Inc. today announced changes to its executive leadership team to further advance its aspirations to discover and develop new medicines and vaccines, with an emphasis on oncology. Under his ...

Each year, I attend the International Leadership Association's conference, which brings together global thought leaders to discuss the evolving landscape of leadership. This year's theme ...

Pfizer is making these changes in preparation for integrating Seagen once the $43 billion merger closes, expected in late 2023 or early 2024. For now, the two companies are operating independently ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / February 4, 2025 / Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI ...